BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 23333927)

  • 1. Characterization and proteomic analysis of ovarian cancer-derived exosomes.
    Liang B; Peng P; Chen S; Li L; Zhang M; Cao D; Yang J; Li H; Gui T; Li X; Shen K
    J Proteomics; 2013 Mar; 80():171-82. PubMed ID: 23333927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics profiling of plasma exosomes in epithelial ovarian cancer: A potential role in the coagulation cascade, diagnosis and prognosis.
    Zhang W; Ou X; Wu X
    Int J Oncol; 2019 May; 54(5):1719-1733. PubMed ID: 30864689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and proteomic analysis of osteoblast-derived exosomes.
    Ge M; Ke R; Cai T; Yang J; Mu X
    Biochem Biophys Res Commun; 2015 Nov; 467(1):27-32. PubMed ID: 26420226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis.
    Yi H; Zheng X; Song J; Shen R; Su Y; Lin D
    Int J Clin Exp Pathol; 2015; 8(12):15719-28. PubMed ID: 26884841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells.
    Cheng L; Zhang K; Qing Y; Li D; Cui M; Jin P; Xu T
    J Ovarian Res; 2020 Jan; 13(1):9. PubMed ID: 31969186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
    Sinha A; Ignatchenko V; Ignatchenko A; Mejia-Guerrero S; Kislinger T
    Biochem Biophys Res Commun; 2014 Mar; 445(4):694-701. PubMed ID: 24434149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and proteomic profiling of pancreatic cancer-derived serum exosomes.
    Jiao YJ; Jin DD; Jiang F; Liu JX; Qu LS; Ni WK; Liu ZX; Lu CH; Ni RZ; Zhu J; Xiao MB
    J Cell Biochem; 2019 Jan; 120(1):988-999. PubMed ID: 30160795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods.
    Greening DW; Xu R; Ji H; Tauro BJ; Simpson RJ
    Methods Mol Biol; 2015; 1295():179-209. PubMed ID: 25820723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of exosomes reveals an association between cell invasiveness and exosomal bioactivity on endothelial and mesenchymal cell migration
    Sharma S; Alharbi M; Kobayashi M; Lai A; Guanzon D; Zuñiga F; Ormazabal V; Palma C; Scholz-Romero K; Rice GE; Hooper JD; Salomon C
    Clin Sci (Lond); 2018 Sep; 132(18):2029-2044. PubMed ID: 30219799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.
    Rauschenberger L; Staar D; Thom K; Scharf C; Venz S; Homuth G; Schlüter R; Brandenburg LO; Ziegler P; Zimmermann U; Weitschies W; Völker U; Lendeckel U; Walther R; Burchardt M; Stope MB
    Prostate; 2016 Mar; 76(4):409-24. PubMed ID: 26643154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-derived miRNAs and ovarian carcinoma progression.
    Vaksman O; Tropé C; Davidson B; Reich R
    Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of exosomal tyrosine receptor kinase B as a potential biomarker in ovarian cancer.
    Li W; Lu Y; Yu X; Yong M; Ma D; Gao Q
    J Cell Biochem; 2019 Apr; 120(4):6361-6369. PubMed ID: 30304550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
    Cheng L; Wu S; Zhang K; Qing Y; Xu T
    J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of exosomes derived from ovarian cancer cells and normal ovarian epithelial cells by nanoparticle tracking analysis.
    Zhang W; Peng P; Kuang Y; Yang J; Cao D; You Y; Shen K
    Tumour Biol; 2016 Mar; 37(3):4213-21. PubMed ID: 26490993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.
    Kobayashi M; Salomon C; Tapia J; Illanes SE; Mitchell MD; Rice GE
    J Transl Med; 2014 Jan; 12():4. PubMed ID: 24393345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome isolation for proteomic analyses and RNA profiling.
    Taylor DD; Zacharias W; Gercel-Taylor C
    Methods Mol Biol; 2011; 728():235-46. PubMed ID: 21468952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ExoCarta: A compendium of exosomal proteins and RNA.
    Mathivanan S; Simpson RJ
    Proteomics; 2009 Nov; 9(21):4997-5000. PubMed ID: 19810033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
    Lazar I; Clement E; Ducoux-Petit M; Denat L; Soldan V; Dauvillier S; Balor S; Burlet-Schiltz O; Larue L; Muller C; Nieto L
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):464-75. PubMed ID: 25950383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle.
    da Silveira JC; Veeramachaneni DN; Winger QA; Carnevale EM; Bouma GJ
    Biol Reprod; 2012 Mar; 86(3):71. PubMed ID: 22116803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.